Product Information
MYCOPHENOLIC ACID DR 360 MG TB is a generic product labeled by Biocon Pharma Inc., priced at $0.2216 per EA under NDC 70377012711. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on Nov 29, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377012711
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA217031FDA Approved
11/29/2023
TE Code
AB
On Market Since
9/30/2024
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLIC ACID DR 360 MG TB has been published 86 times since Feb 12, 2025, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2216 per EA |
|---|---|
| All-time high | $0.3097 (Apr 16, 2025) |
| All-time low | $0.2216 (Sep 23, 2026) |
| 52-week high | $0.2544 |
| 52-week low | $0.2216 |
| Median price | $0.2456 |
| Average price | $0.2573 |
| Largest weekly change | +7.2% (Feb 19, 2025) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mycophenolic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLIC ACID DR 360 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLIC ACID DR 360 MG TB, manufactured by Biocon Pharma Inc., is $0.2216 per EA (NDC 70377012711), effective Sep 30, 2026.
How has the price of MYCOPHENOLIC ACID DR 360 MG TB changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLIC ACID DR 360 MG TB has declined 19.0%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLIC ACID DR 360 MG TB?
Since Feb 12, 2025, the NADAC for MYCOPHENOLIC ACID DR 360 MG TB has ranged from a low of $0.2216 (Sep 23, 2026) to a high of $0.3097 (Apr 16, 2025), with a median of $0.2456 per EA.
Are there cheaper alternatives to MYCOPHENOLIC ACID DR 360 MG TB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLIC ACID DR 360 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLIC ACID DR 360 MG TB?
MYCOPHENOLIC ACID DR 360 MG TB (NDC 70377012711) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.